002688 金河生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.0524.4603.8703.2454.638
总资产报酬率 ROA (%)2.4761.8051.7361.7642.526
投入资产回报率 ROIC (%)2.8822.1002.0082.0212.844

边际利润分析
销售毛利率 (%)33.82833.50929.55228.91631.332
营业利润率 (%)7.9474.1574.8175.7126.723
息税前利润/营业总收入 (%)11.2086.9476.8765.94010.000
净利润/营业总收入 (%)6.6193.5574.3445.5645.875

收益指标分析
经营活动净收益/利润总额(%)88.489196.094114.388116.439100.918
价值变动净收益/利润总额(%)-0.577-1.252-1.502-3.3120.000
营业外收支净额/利润总额(%)-0.658-0.785-3.189-2.0162.239

偿债能力分析
流动比率 (X)0.9401.0860.9041.0491.418
速动比率 (X)0.6100.7440.6060.6430.922
资产负债率 (%)53.45155.75953.85546.20633.658
带息债务/全部投入资本 (%)45.53747.07448.16540.28928.133
股东权益/带息债务 (%)107.60298.27099.542140.469243.730
股东权益/负债合计 (%)78.70571.30476.496106.646178.228
利息保障倍数 (X)3.3822.4623.11517.4263.202

营运能力分析
应收账款周转天数 (天)66.44572.99372.21264.63856.641
存货周转天数 (天)131.097149.119158.238149.484129.231